The molecular mechanisms of prion-induced cytotoxicity remain largely obscure. Currently, only a few cell culture models have exhibited the cytopathic changes associated with prion infection. In this study, we introduced a cell culture model based on differentiated neurosphere cultures isolated from the brains of neonatal prion protein (PrP)-null mice and transgenic mice expressing murine PrP (dNP0 and dNP20 cultures). Upon exposure to mouse Chandler prions, dNP20 cultures supported the de novo formation of abnormal PrP and the resulting infectivity, as assessed by bioassays. Furthermore, this culture was susceptible to various prion strains, including mouse-adapted scrapie, bovine spongiform encephalopathy, and Gerstmann-Sträussler-Scheinker syndrome prions. Importantly, a subset of the cells in the infected culture that was mainly composed of astrocyte lineage cells consistently displayed late-occurring, progressive signs of cytotoxicity as evidenced by morphological alterations, decreased cell viability, and increased lactate dehydrogenase release. These signs of cytotoxicity were not observed in infected dNP0 cultures, suggesting the requirement of endogenous PrP expression for prion-induced cytotoxicity. Degenerated cells positive for glial fibrillary acidic protein accumulated abnormal PrP and exhibited features of apoptotic death as assessed by active caspase-3 and terminal deoxynucleotidyltransferase nick-end staining. Furthermore, caspase inhibition provided partial protection from prion-mediated cell death. These results suggest that differentiated neurosphere cultures can provide an in vitro bioassay for mouse prions and permit the study of the molecular basis for prion-induced cytotoxicity at the cellular level. P rion diseases comprise a class of transmissible, fatal, neurodegenerative diseases, and they include Creutzfeldt-Jakob disease (CJD) and Gerstmann-Straussler-Scheinker syndrome (GSS) in humans, bovine spongiform encephalopathy (BSE) in cattle, scrapie in sheep and goats, and chronic wasting disease in deer. The neuropathological hallmarks of prion diseases are neuronal loss, vacuolation, synaptic alterations, astrogliosis, microglial activation, and the progressive accumulation of a misfolded and protease-resistant isoform (PrPres) of host-encoded proteasesensitive prion protein (protease-sensitive PrP [PrPsen]). The conversion of PrPsen into PrPres and its accumulation are implicated in the pathogenesis of prion diseases (1, 2); however, the molecular basis of neurodegeneration in prion diseases is largely unclear.
P
rion diseases comprise a class of transmissible, fatal, neurodegenerative diseases, and they include Creutzfeldt-Jakob disease (CJD) and Gerstmann-Straussler-Scheinker syndrome (GSS) in humans, bovine spongiform encephalopathy (BSE) in cattle, scrapie in sheep and goats, and chronic wasting disease in deer. The neuropathological hallmarks of prion diseases are neuronal loss, vacuolation, synaptic alterations, astrogliosis, microglial activation, and the progressive accumulation of a misfolded and protease-resistant isoform (PrPres) of host-encoded proteasesensitive prion protein (protease-sensitive PrP [PrPsen] ). The conversion of PrPsen into PrPres and its accumulation are implicated in the pathogenesis of prion diseases (1, 2) ; however, the molecular basis of neurodegeneration in prion diseases is largely unclear.
Several lines of evidence have revealed that animals can harbor high levels of infectivity before or without developing clinical signs (3, 4) , indicating the decoupling of prion infectivity from toxicity. One possible explanation for the dissociation is that toxic species of PrPres distinct from the infectious particles are produced after reaching a plateau of infectivity (4) . Investigations of the function of putative toxic forms of PrP and PrP in toxic signaling are crucial for understanding the pathogenesis of prion diseases and the development of effective treatments for these disorders. Although rodent experimental models have contributed to the progress of prion research, there are limitations of wholeanimal studies, including costs, the long time required to complete testing, and the difficulty in identifying mechanisms involved in prion propagation and pathogenesis at the molecular and cellular levels. Thus, developing a cellular model capable of monitoring prion-induced cytotoxicity would be a promising approach for better understanding the molecular nature of toxic particles and their molecular mechanisms of cytotoxicity. However, to date, only a few cell culture models have exhibited the cytopathic changes associated with prion infection (5) (6) (7) (8) . One candidate cellular assay that is expected to be sensitive to prioninduced cytotoxicity is a model based on neurospheres, which contain neural stem cells (NSCs) that are capable of self-renewal and multilineage differentiation, including neurons, astrocytes, and oligodendrocytes (9) . Indeed, both undifferentiated and differentiated neurospheres/NSCs have been demonstrated to be permissive to prion infection (10) (11) (12) . In addition, cell death in differentiated NSC models of prion diseases was briefly described (11) ; however, detailed information has not yet been provided.
In this study, we developed a cell culture model based on differentiated neurosphere cultures (dNP20 cultures) isolated from neonatal transgenic mice overexpressing murine PrP. This model is sensitive to prion infection and susceptible to multiple prion strains. Of note, a subset of cells in infected dNP20 cultures consistently displayed late-occurring, progressive cytopathic changes associated with apoptosis in astrocyte lineage cells. The neurosphere-based model holds great promise for detecting prion infectivity, understanding the molecular mechanisms of prion-induced cytotoxicity, and developing molecular therapeutics for prion diseases. mice) at day 0 after birth. After the removal of meninges, cortices were minced and incubated in phosphate-buffered saline without calcium and magnesium (PBS) containing 1 mM EDTA, 100 g/ml trypsin, and 400 g/ml DNase I for 15 min at 37°C with constant agitation. After fetal calf serum was added, the cell suspensions were prepared by repeated passage through a fine-bore pipette and briefly placed in 15-ml centrifuge tubes. Cell suspensions without tissue fragments were collected and centrifuged at 200 ϫ g for 5 min. Cells were suspended in Dulbecco's modified Eagle's medium-nutrient F-12 Ham (Sigma D8437) supplemented with N-2 factors (N-2 supplement; Life Technologies Corporation, Carlsbad, CA, USA), 50 ng/ml epidermal growth factor (EGF) (Sigma E9644), 50 ng/ml basic fibroblast growth factor (bFGF) (Sigma F0291), and penicillin and streptomycin (Sigma P0781) and recentrifuged at 200 ϫ g for 5 min. Cells were resuspended in culture medium and plated in 60-mm culture dishes having low adherability (HydroCell; CellSeed, Tokyo, Japan). Cultures were maintained at 37°C with 5% CO 2 as floating spheres with daily medium addition for 4 or 5 days. Spheres were dissociated in a solution of proteolytic and collagenolytic enzymes (Accutase; Innovative Cell Technologies, San Diego, CA) at 37°C for 10 min with trituration and passed at 1:4 every 3 to 4 days.
Cell differentiation and prion infection. For monolayer cultures, coated glass coverslips and plates were used. Glass coverslips (22 by 22 mm; Asahi Glass, Tokyo, Japan) were incubated overnight with 3 M HCl in ethanol at room temperature with gentle rocking. After washing with acetone, coverslips were incubated overnight with 12.5 g/ml fibronectin (Sigma) at 37°C in a humidified incubator and desiccated overnight at 37°C. Multiwell culture plates or chambers were pretreated similarly excluding HCl treatment. Single-cell suspensions were prepared by Accutase treatment with trituration and plated at 200,000 cells per coverslip on fibronectin-coated glass coverslips in 6-well plates for 3 days upon reaching 90% confluence. Differentiation was induced by bFGF withdrawal, and culture medium was replaced every 2 days. At day 6 after differentiation, cultures were treated with various concentrations of prion-infected or uninfected brain homogenates (homogenized in PBS, 10% [wt/vol] stock) or semipurified PrPres (30 g/ml stock) diluted in 2 ml of culture medium and incubated. After 48 h, the culture medium was replaced with fresh medium containing the same inoculum, and the cultures were incubated for another 48 h (a total of two exposures in 4 days). Culture medium was changed every 2 days.
Western blot analysis. Whole-cell extracts were prepared with lysis buffer containing 10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA with 0.5% Triton X-100, 0.5% sodium deoxycholate, and protease and phosphatase inhibitors (Complete and PhoStop; Roche Diagnostics, Basel, Switzerland). After the removal of insoluble debris by centrifugation at 10,000 ϫ g for 2 min, the total protein concentrations of the samples were measured by the bicinchoninic acid assay (BCA protein assay; Thermo Fisher Scientific, Rockland, IL, USA), and equal amounts of protein (3 to 4 g) were analyzed.
For PrPres detection, the same amount of protein (25 g) was precipitated with ice-cold methanol and treated with 5 g of proteinase K in 40 l of extract buffer (the final concentration of PK was 125 g/ml) for 30 Germany). All images using the same primary antibody were taken under the same conditions of exposure/background settings. The number of shrinking glial fibrillary acidic protein (GFAP)-positive cells were analyzed using a BZ-9000 fluorescence microscope (Keyence, Osaka, Japan) and the accompanying image reader software according to the manufacturer's instructions.
Infectivity assay. The infectivity associated with dNP0 and dNP20 cultures was assayed by intracerebral inoculation into murine PrP-overexpressing (tga20) mice. Cells were scraped in 400 l of sterile PBS, freezethawed, and sonicated briefly. Tenfold-diluted cell extracts were intracerebrally inoculated into mice (20 l/head). After inoculation, the terminally ill mice were sacrificed for Western blotting of the brain tissues. All mice were kept in an air-conditioned room and fed standard laboratory food pellets and water ad libitum. Procedures involving animal subjects were approved by the Institutional Animal Care and Use Committee at the National Institute of Animal Health.
Analysis of cytotoxicity and apoptosis. Prion-mediated cytotoxicity was determined by both lactate dehydrogenase (LDH) release (CytoTox-ONE homogeneous membrane integrity assay; Promega) and WST-8 reduction assays (cell counting kit 8; Dojindo Lab, Kumamoto, Japan). Single-cell suspensions were plated in the wells of 24-well plates (5 ϫ 10 4 cells/well) coated by fibronectin and differentiated before infection with Chandler prions. Half of the medium was replaced with fresh medium every 2 days, and cell death and caspase activation were assessed at 18 days postinfection (dpi).
LDH release and WST-8 assays were conducted according to the manufacturer's instructions. In the WST-8 assay, the absorbance values of infected cultures were expressed as a percentage of those of mock or uninfected cultures. The percent LDH release was calculated with reference to the maximum LDH release measured after cell lysis (100%). Caspase activation was measured using the Caspase-Glo 3/7, Caspase-Glo 8, and Caspase-Glo 9 assays (Promega), following the manufacturer's recommendations. For caspase inhibition experiments, cultures were incubated with 30 M z-VAD-fmk (general caspase inhibitor) at 6 dpi with or without Chandler prions. Half of the medium was replaced with fresh medium containing z-VAD-fmk every 2 days. Cell death was assessed by WST-8 reduction and LDH release assays at 18 dpi. To detect fragmented DNA, at 15 dpi, the cultures were fixed with 4% paraformaldehyde and permeabilized with ice-cold methanol (MeOH). Terminal deoxynucleotidyltransferase nick-end (TUNEL) staining was performed using an in situ cell death detection kit (fluorescein) (Roche Molecular Biochemicals, Mannheim, Germany), according to the manufacturer's instructions. Bioactive substances in both the medium and cell extracts of infected dNS20 cultures at 18 dpi were measured using a mouse cytokine antibody array (RayBio mouse cytokine arrays 3 and 4; RayBiotech, Norcross, GA, USA).
PrPres purification. PrPres was concentrated by the purification method of scrapie-associated fibrils (17, 18) with slight modification. Brains were dissected from either uninfected control mice or terminally ill mice with Chandler murine scrapie and stored at Ϫ80°C until use. Brains were homogenized in 3 ml of buffer A (0.5 mM CaCl 2 , 0.5 mM MgCl 2 , and 10% Sarkosyl in 10 mM Tris-HCl, pH 7.4) supplemented with 250 U/ml endonuclease (TurboNuclease; Accelagen, San Diego, CA, USA) using a Multi-Beads Shocker cell disruptor (Yasui Kikai Corporation, Osaka, Japan). The homogenate was incubated at room temperature for 30 min. The homogenate was centrifuged at 22,000 ϫ g for 20 min at 4°C. The supernatant was centrifuged at 410,000 ϫ g using a Beckman TLA 100.4 rotor for 20 min at 4°C. The pellet was resuspended in 500 l of buffer B (1% Sarkosyl in 10 mM Tris-HCl, pH 7.4, and 10% NaCl) and sonicated briefly before digestion with 25 g/ml proteinase K (PK) for 30 min at 37°C. Digestion was stopped with 4 mM Pefabloc (Roche Molecular Biochemicals). The digest was centrifuged at 22,000 ϫ g for 20 min at 4°C. The pellets were resuspended in 500 l of buffer B and recentrifuged at 22,000 ϫ g for 20 min at 4°C. The pellets were resuspended in 50 l of PBS.
Statistical analysis. Values shown in the figures are expressed as means Ϯ standard deviations (SD). To determine statistical significance, Welch's t test for unpaired data was applied as appropriate. A P value of Ͻ0.05 was considered significant. Statistical analysis of all data was performed using the Excel software program.
RESULTS

PrP and cell marker expression during differentiation of neural stem cells.
Neurosphere cultures isolated from PrP-null mice and tga20 mice (NP0 and NP20) were passaged more than eight times through the combination of enzymatic and mechanical dissociation. Then, single-cell suspensions of neurospheres were cultured in monolayers on cover glass precoated with fibronectin for 3 days, and portions of the cultures were harvested as undifferentiated cultures. The remaining cultures were differentiated by the withdrawal of only bFGF and harvested at 6 days postdifferentiation (dNP0 and dNP20 cultures). The cell extracts were then analyzed by Western blotting using antibodies against nestin, a marker of potential neural stem cells; neuronal class III ␤-tubulin (Tuj1), a marker of early neuronal lineages; GFAP, a marker of astrocyte lineage cells; 2=,3=-cyclic nucleotide 3=-phosphodiesterase (CNPase), a marker of oligodendrocyte lineages; and PrP. After bFGF withdrawal, the levels of neural and glial lineage markers and PrP were markedly increased, whereas those of nestin were decreased ( Fig. 1) , suggesting that neurosphere cultures maintained the properties of self-renewal and multipotency. Neurosphere cultures were differentiated in the absence of bFGF but in the presence of EGF because the neurosphere cultures that differentiated upon the withdrawal of both growth factors partly detached and did not form confluent monolayer cultures on cover glass (data not shown). dNP20 cultures efficiently support de novo PrPres formation. In the preliminary experiments, undifferentiated NP20 cultures were not susceptible to prion infection and subcloning of NP20 cultures did not improve their susceptibility (data not shown). We next examined the susceptibility of differentiated NP20 cultures (dNP20 cultures) to prion infection. Because the differentiated neurosphere cultures were not passaged after prion infection, the input PrPres and infectivity remaining in the cultures should be considered. To verify the de novo replication of prions, dNP0 cultures were infected in parallel as a negative control. This enabled us to monitor the infectivity and PrPres levels of the residual inocula throughout the experiment.
At 6 days postdifferentiation, dNP0 and dNP20 cultures were exposed to 2 ml of 0.1% (wt/vol) dilution of Chandler homogenates (a total of two exposures in 4 days) as described in Materials and Methods. To study the kinetics of PrPres accumulation, cultures were lysed at 6, 12, and 18 dpi and untreated and PK-treated lysates were analyzed by Western blotting. During the course of infection, gradual PrPres accumulation was observed reproducibly in infected dNP20 cultures ( Fig. 2A) . In contrast, in infected dNP0 cultures, PrPres was barely detectable at 6 dpi and was undetectable at 12 and 18 dpi.
To further confirm aggregated PrP accumulation in infected cultures, dNP0 and dNP20 cultures fixed at 15 dpi were treated with 5 M GdnSCN and examined after immunofluorescence staining of PrP using MAb 132 (14) . Intense and granular fluorescence, which was assumed to reflect aggregated PrP accumulation, could be observed throughout the layers of infected dNP20 cultures, in sharp contrast with the weak signals obtained with mockinfected dNP0 and dNP20 cultures and infected dNP0 cultures (Fig. 2B) . These results suggest that dNP20 cultures effectively replicated PrPres, whereas PrP-deficient dNP0 cells did not support PrPres formation upon exposure to the Chandler strain.
To evaluate the sensitivity of the model, dNP20 cultures were twice exposed to 2 ml of serial 10-fold dilutions of 0.1% (wt/vol) Chandler brain homogenates (1 ϫ 10 Ϫ5 to 1 ϫ 10 Ϫ1 %). In parallel, to monitor the levels of residual input PrPres, dNP0 cells were exposed to the same inocula. The accumulation of PrPres in these cultures was examined by Western blot analysis at 18 dpi. PrPres was barely detectable in dNP20 cultures exposed to 2 ml of 1 ϫ 10 Ϫ5 % (wt/vol) Chandler brain homogenates, indicating that prion infectivity could be detected from 4 g of Chandler brain tissue equivalent (Fig. 2C) .
To further eliminate the possibility that the PrPres accumulation observed in dNP20 cultures was due to the accumulation of PrPres of the residual inocula, we designed an experiment to directly monitor the fate of input PrPres during the course of the experiment. Both dNP0 and dNP20 cultures were twice exposed to 2 ml of 0.1% (wt/vol) brain homogenates of transgenic mice carrying chimeric mouse/hamster PrP genes (MHM2 mice) (19) with the Chandler murine scrapie strain. Western blot analysis using 3F4 MAb made it possible to detect the only input PrPres, because 3F4 MAb reacts with PrPres from humans and hamsters but not with PrPres from other species, including mice. Kinetic analysis demonstrated a decrease in the amount of 3F4-positive PrPres in the residual inocula, whereas the amount of T2-positive total PrPres increased in a time-dependent manner (Fig. 2D) . We concluded that dNP20 cultures could support de novo PrPres formation.
Infectivity in dNP20 cultures exposed to Chandler murine scrapie. To examine whether prion infectivity increased concomitantly with PrPres accumulation, the infectivity in dNP0 and dNP20 cultures at 18 dpi was assayed using tga20 mice. Inoculation of tga20 mice (n ϭ 6) with infected dNP20 cultures resulted in a mean incubation period of 62.8 Ϯ 3.2 days, which was significantly shorter than the 85.0 Ϯ 3.0 days in tga20 mice (n ϭ 6) inoculated with infected dNP0 cultures. The accumulation of PrPres in their brains was confirmed by Western blotting. None of the mice inoculated with mock-infected dNP0 or dNP20 cultures exhibited scrapie symptoms. The infectious titers generated in dNP20 cultures were approximately 3 orders of magnitude higher than those in infected dNP0 cultures, which corresponded to the levels of the residual inoculum. These results demonstrated that PrPres formation in dNP20 cultures was accompanied by the substantial generation of prion infectivity.
Differentiated NP20 cultures susceptible to infection with multiple prion strains. To assess the susceptibilities of dNP20 cultures to other murine prion strains, dNP0 and dNP20 cultures were twice exposed to 2 ml of 0.1% (wt/vol) dilutions of brain homogenates from terminally ill mice infected with mouseadapted scrapie (Chandler, ME7, and 22L strains), BSE, and GSS. The accumulation of PrPres in these cultures was confirmed by Western blot analysis at 18 days after exposure. All tested prion strains promoted substantial accumulation of PrPres in dNP20 cultures but not in dNP0 cultures (Fig. 3A) . Interestingly, the unglycosylated fragments of PrPres derived from murine BSE-and GSS-infected dNP20 cultures migrated differently from those of the murine scrapie strain-infected cultures, migrating slightly faster in BSE-infected cultures and slower in GSS-infected cultures. These results are consistent with PrPres replication in mice (Fig. 3B) and with previous findings with mouse-adapted BSEinfected MG20 cells (20) and GSS-infected GT1-7 cells (21) . Taken together, our data revealed that dNP20 cultures represent a susceptible model for various prion infections.
Infected dNP20 cultures display progressive cytopathic changes. During infection, we observed gross morphological alterations in infected dNP20 cultures on coated glass coverslips compared with the findings in uninfected cultures. The early cytopathic changes became apparent at 12 dpi and were characterized by focal degeneration, including the formation of cellular aggregates in marginal regions of the culture monolayers and the markers. Single-cell suspensions of neurospheres isolated from PrP-null mice and tga20 mice (NP0 and NP20 cultures) were cultured in monolayers in the presence of bFGF for 3 days, and portions of the cultures were harvested. The rest of the culture was differentiated by bFGF withdrawal for 6 days and harvested (dNP0 and dNP20 cultures). The levels of PrP and marker proteins were analyzed by Western blotting using antibodies against nestin, a marker of potential neural stem cells, Tuj1, a marker of early neuronal lineage cells, GFAP, a marker of astrocyte lineage cells, CNPase, a marker of oligodendrocyte lineage cells, and PrP. ␤-Actin was used to normalize total protein levels.
detachment of some cells. The progressive changes became more prominent at 18 dpi, when there was widespread formation of cellular aggregates and continuing detachment of cells, resulting in total destruction of the culture monolayer (Fig. 4A) .
Prion-associated cytopathic changes were also evaluated by WST-8 reduction and LDH release assays at 6, 12, and 18 dpi. In agreement with the morphological changes of cells, reduction in cell viability and disruption of membrane integrity became apparent at 12 dpi in infected dNP20 cultures (Fig. 4B and C) . In contrast, there were no detectable cytopathic changes in infected dNP0 cultures. It is noteworthy that dNP20 cultures infected with semipurified PrPres also exhibited late-occurring signs of cytotoxicity, suggesting that prion-induced cytotoxicity was directly related to de novo prion replication in cultures rather than the acute toxicity of PrPres or bioactive substances in brain homogenates.
Cytopathic changes were observed in cells of the astrocyte lineage. The cell types displaying morphological abnormalities were determined by immunocytochemistry. To avoid any possible artifact attributable to the brain homogenates, dNP20 cultures were exposed to semipurified PrPres and examined by immunofluorescence staining of the indicated cell markers using anti-GFAP, antinestin, and anti-Tuj1 antibodies at 15 dpi. To our surprise, we found that GFAP-positive cells exhibited severe shrinkage, rounding, and cytoplasmic condensation (Fig. 5A) . The number of shrunken GFAP-positive cells was significantly increased in infected dNP20 cultures (Fig. 5B) .
To assess marker protein expression, dNP20 culture extracts at 18 dpi were subjected to semiquantitative Western blot analysis. Consistent with the immunocytochemical findings, the levels of GFAP were decreased by approximately 40% (Fig. 5C and D) , and thus we roughly estimated that around 40% GFAP-positive cells had degenerated. On the contrary, the levels of nestin and Tuj1 were elevated by approximately 150% and 430%, respectively. There was no significant difference in CNPase levels between infected and uninfected cultures.
The presence of GFAP, a classical marker for astrocytes (22) ,
FIG 2 Accumulation of PrPres in dNP20 cultures exposed to the Chandler strain. (A) Western blot analysis of total PrP and PrPres levels in cultures.
Both dNP20 and dNP0 cultures were exposed to 2 ml of 0.01% Chandler-infected (Chan) or normal (Mock) brain homogenates of CD1 mice diluted in medium, cultured, and harvested at 6, 12, and 18 dpi. dNP0 cultures were used to control residual signals from the inoculum. Total PrP (upper panel) and PrPres (middle panel) levels in untreated or PK-treated culture extracts were measured by Western blotting using T2 MAb. ␤-Actin was used to normalize total protein levels. (B) Confocal fluorescence microscopic analysis of aggregated PrP accumulation in cultures at 16 dpi. Fixed, permeabilized, and GdnSCN-denaturized dNP0 and dNP20 cultures were stained with anti-PrP MAb 132 followed by Alexa Fluor 488-conjugated secondary antibody (green). Nuclei were counterstained with Topro-3 (blue). Punctate fluorescence assumed to reflect aggregated PrP accumulation was observed in infected dNP20 cultures. Scale bar, 20 m. (C) Sensitivity of dNP20 cultures. Both dNP0 and dNP20 cultures were exposed to 2 ml of serial 10-fold dilutions of 0.1% Chandler-infected brain homogenates diluted in medium (final concentration, 1 ϫ 10 Ϫ5 to 1 ϫ 10 Ϫ1 %) and harvested at 18 dpi. Cell extracts either with (lower panel) or without (upper panel) PK treatment were analyzed by Western blotting. Molecular mass standards (kDa) are indicated on the right. ␤-Actin was used as a control to confirm the protein content of the cell extracts. (D) Kinetics of PrPres in the residual inocula and total PrPres accumulation between 6 and 18 dpi. Both dNP20 and dNP0 cultures were exposed to 2 ml of 0.01% Chandler-infected (Chan) or normal (Mock) brain homogenate of MHM2 mice diluted in medium, cultured, and harvested at 6, 12, and 18 dpi. PrPres levels in PK-treated culture extracts were measured by Western blotting using T2 or 3F4 MAb. PrPres detected by 3F4 MAb represents PrPres of the residual inocula. Molecular mass standards (kDa) are indicated on the right. ␤-Actin was used as a control to confirm the protein content of the cell extracts.
does not necessarily imply that cells are mature astrocytes. GFAP is expressed in radial glial and neural stem/progenitor cells, which possess certain astrocytic characteristics, in the developing nervous system and adult brain, respectively (23) (24) (25) . Therefore, to examine the nature of degenerated GFAP-positive cells in dNP20 cultures, we analyzed the levels of the stem cell marker Sox2, the radial glial cell markers brain fatty acid binding protein/brain lipid binding protein (BLBP) and vimentin, the astrocyte marker S100B, and the radial glial cell and astrocyte marker excitatory amino acid transporter 1/L-glutamate/L-aspartate transporter (GLAST) (26) (27) (28) (29) (30) by Western blotting. In infected dNP20 cultures, the levels of S100B and GLAST were significantly reduced ( Fig. 5C and D) . These data suggest that prions may induce cell death in a subset of astrocyte lineage cells but not in GFAP-expressing radial glial or neural stem/progenitor cells.
Of note, S100B has been associated with oligodendrocyte precursors (31, 32) ; thus, we examined the levels of oligodendrocyte markers. However, no detectable reduction was observed in the levels of the oligodendrocytes precursor markers Olig2 (33) and NG2 (34), the premyelinating oligodendrocytes marker CNPase (35) , or the myelinating oligodendrocyte marker myelin basic protein (MBP) (36) in infected dNP20 cultures (Fig. 5C and D) , suggesting that prions did not induce cell death in oligodendrocyte precursors.
PrPres formation induced cytopathic effects in GFAP-positive cells. To ensure the correlation between PrPres accumulation and changes in the levels of cell markers, dNP20 cultures exposed to 0.5 g of semipurified PrPres were harvested at 6, 12, and 18 dpi, and the kinetics of the expression of cell marker proteins was analyzed by Western blotting (Fig. 6A, left panel) . The reduction in GFAP levels and the elevation in Tuj1 and nestin levels appeared to be correlated with the elevation of PrPres levels in a time-dependent manner. In addition, Western blot analysis performed on dNP20 cultures after 18 days of infection with serial 10-fold dilutions of PrPres (0.05 to 500 ng) revealed the dosedependent effects of de novo PrPres, which increased proportionally with the amount of input, on changes in the levels of GFAP, Tuj1, and nestin (Fig. 6A, right panel) .
To determine whether PrPres accumulated in degenerated GFAP-positive cells, infected dNP20 cultures were examined using dual immunofluorescent labeling for PrP and GFAP after denaturation with GdnSCN at 15 dpi. We found that PrPres accumulation colocalized with shrinking GFAP-positive cells in infected dNP20 cultures (Fig. 6B) . These results suggested that continuous PrPres formation in cultures induced cytopathic effects in the GFAP-positive cells.
Increased apoptosis in infected dNP20 cultures. In an attempt to identify the mechanisms of prion-mediated cell death, we first monitored the activation of caspases in infected dNP0 and dNP20 cultures at 18 dpi. There was a sharp increase in caspase-3/7, caspase-8, and caspase-9 activity in the infected dNP20 cultures compared with that in the uninfected cultures (Fig. 7A) .
We next performed Western blot analysis of cell lysates from dNP20 cultures infected with or without PrPres using antibodies against the cleaved forms of caspase-3, caspase-8, and caspase-9 and the cleaved form of the caspase substrate PARP. Consistent with the caspase activity data, a time course study demonstrated that cleaved PARP and caspase-3, caspase-8, and caspase-9 levels increased in infected dNP20 cultures in a time-dependent manner (Fig. 7B) . Background caspase levels were detected in noninfected dNP20 cultures, possibly due to basal apoptosis in dNP20 cultures.
To determine whether apoptotic responses were elicited in degenerated GFAP-positive cells, we performed dual immunofluorescent labeling for cleaved caspase-3 and GFAP in infected dNP20 cultures. In addition, apoptosis was further confirmed by the colocalization of degenerated GFAP-positive cells and TUNEL staining. We found that cleaved caspase-3 and TUNEL staining colocalized with degenerated GFAP-positive cells in infected dNP20 cultures (Fig. 7C) .
Finally, we examined whether pharmacological inhibition of caspases had any effect on prion-associated cell death. We treated dNP0 and dNP20 cultures infected with or without PrPres with the pancaspase inhibitor z-VAD-fmk beginning at 6 dpi and assessed cell death by WST-8 reduction and LDH release assays at 18 dpi. We observed that z-VAD-fmk partially blocked cell death in infected dNP20 cultures ( Fig. 7D and E) without affecting PrPres accumulation (data not shown). Collectively, these data suggested that prion-mediated cell death in astrocyte lineage cells was at least in part associated with apoptosis. Observations of increased active caspase-8 expression in the present study raise the possibility that apoptosis in infected dNP20 cultures may be induced through death receptors (DRs) (e.g., Fas, tumor necrosis factor-alpha [TNF-␣] receptor, DR3, DR4, and DR5) by their respective ligands. To investigate this possibility, we exposed untreated dNP20 cultures to the conditioned medium collected from infected cultures at 16 dpi for 2 days. However, no detectable reduction in cell viability was observed in the exposed cultures (data not shown). Moreover, cytokine antibody arrays revealed no detectable elevation of the levels of Fas ligand, gamma interferon (IFN-␥), TNF-␣, and interleukins (ILs), including IL-1␣, IL-1␤, IL-5, IL-6, IL-9, IL-10, IL-12p40/70, IL-13, and IL-17, with the exception of elevated levels of IL-4 and IL-12p70 in both the medium and cell extracts of infected dNP20 cultures at 18 dpi (data not shown). 
DISCUSSION
In this study, we observed that differentiated neurosphere cultures (dNP20) isolated from PrP-overexpressing mice were susceptible to a broad range of prion strains. Importantly, a subset of cells in dNP20 cultures consistently exhibited the late-occurring and progressive cytopathic changes associated with prion replication. These changes were observed mainly in GFAP-positive astrocyte lineage cells in dNP20 cultures and induced, at least in part, by apoptosis.
We revealed that dNP20 cultures allowed the propagation of various prion strains, including mouse-adapted scrapie, BSE, and GSS. The high susceptibility of dNP20 cultures may be attributable to their heterogeneous population of cells, partly mimicking the brain environment in vitro. Neurosphere cultures are known to be differentiated into three main cell types in the brain, neurons, astrocytes, and oligodendrocytes, and in fact, we observed elevated levels of marker proteins for these cells after differentiation of the cultures. In addition, we found that the glycosylation patterns and the molecular size of the unglycosylated PrPres accumulated in dNP20 cultures infected with various strains closely resembled those observed in brains (Fig. 3B) . Because the distribution of PrPres in the brain is known to differ among prion strains, conceivably reflecting the preferential replication of certain strains in certain cell types of the brain (37) , and the cell context in which prion replication occurs is assumed to affect the molecular characteristics of PrPres (38) , it would be intriguing to examine whether each strain preferentially replicates in certain cell types in dNP20 cultures.
In contrast, Herva and colleagues reported that differentiated neurosphere cultures isolated from the 14-day embryos of tga20 mice are susceptible to RML and 22L but not to mouse-adapted BSE (12) . Despite the usage of neurosphere cultures isolated from the same mouse strain, the reason for the differences in prion susceptibility is uncertain. It has been demonstrated that neurospheres are heterogeneous with regard to size, cell type composition, and cellular properties (39) . These heterogeneities are increased by differences in culturing methods, such as the concentrations of growth factors in the medium and the method and frequency of passaging (40) . Indeed, we isolated the neurosphere cultures from neonatal mouse brains and infected the cultures after more than eight passages of primary spheres in undifferentiated culture medium. Thus, it is conceivable that the methodological procedure used in the present study may alter the molecular expression characteristics of neurosphere cultures and affect their cell fate, which in turn may influence the microenvironments associated with prion susceptibility.
Our study suggests that cells expressing GFAP displayed morphological abnormalities, and the levels of astroglial markers, including GFAP, GLAST, and S100B, were significantly reduced in infected dNP20 cultures. On the contrary, no reduction in the levels of neural, oligodendroglial, and radial glial cell marker expression was observed. Thus, it is most likely that prions induced cytopathic changes in astrocyte lineage cells in dNP20 cultures. However, these observations appear to contradict those of previous studies in which astrocytes were observed to be permissive to prion infection in vivo and in vitro (6, (41) (42) (43) (44) ; nonetheless, there is no evidence to suggest astrocyte loss or degeneration during prion infection in vivo (45) and in slice cultures (46) . A possible explanation for this discrepancy is that dNP20 cultures contained immature astrocytes, and these cells may be susceptible to prioninduced cytotoxicity. To grow dense monolayer cultures, we differentiated neurosphere cultures by withdrawing only bFGF and cultivated cells in the presence of EGF and N2 supplement. EGF itself supports stem cell growth (47) and maintains astrocytes in a relatively immature state (48) . In accord with these reports, most of the GFAP-positive cells in dNP20 cultures consisted mainly of thin-bodied cells with long, slender cellular processes, whereas there were fewer multipolar cells with a typical stellate morphology, suggestive of a more mature phenotype (Fig. 5A ). In addition, we observed that cells positive for CD44, which has recently been associated with astrocyte precursors in the developing central nervous system (49) (50) (51) , displayed morphological abnormalities in infected dNP20 cultures (data not shown). Considering our present data together with previous findings, we propose that prions may induce cytopathic changes in astrocyte lineage cells, which may not differentiate into fully mature astrocytes. The recent finding that a major source of astrocytes in the postnatal mouse brain is the local proliferation of differentiated astrocytes, which undergo symmetric division, and not glial progenitors in the subventricular zone (52) may explain the absence of astrocyte loss during prion infection. Thus, our differentiated neurosphere culture model might not directly reflect in vivo disease pathogenesis but might rather implicate prion toxicity in immature astrocytic lineage cells under the specific culture conditions. The precise mechanisms of cell death restricted to immature astrocytes are yet to be determined.
The current data indicate that apoptosis plays a major role in prion-induced cytotoxicity in dNP20 cultures; however, the precise mechanisms by which prions induce apoptosis are unclear. Apoptosis is a highly regulated cell death mechanism induced through numerous different pathways, including the extracellular ligand-mediated extrinsic pathway, mitochondrion-mediated intrinsic pathway, and endoplasmic reticulum (ER)-mediated pathway. Each pathway is closely coupled to initiator caspases, as follows: caspase-8 and caspase-10 in the extracellular ligand-mediated pathway, caspase-2 and caspase-9 in the mitochondrionmediated pathway, and caspase-12 in the ER-mediated pathway. Apoptotic cell death has been implicated in prion diseases, and active caspase-3 and TUNEL staining indicative of apoptosis have been detected in the brains of humans with CJD (53), mice (54) (55) (56) (57) (58) , and cell culture (6) models of prion diseases. In addition, the activation of caspase-12 has been observed in scrapie-infected mice and in patients with CJD, implicating ER stress and neurodegeneration in prion diseases (59, 60) . We observed the activation of caspase-8 and caspase-9 but failed to detect the proteolytic cleavage of caspase-12 in infected dNP20 cultures (data not shown). Experiments are under way to explore whether ER stress was induced in infected dNP20 cultures.
We investigated the possibility that apoptosis in infected dNP20 cultures was induced through death receptors (DRs) by their respective ligands. However, we could not detect the elevation of the levels of Fas ligand, IFN-␥, and TNF-␣ by cytokine antibody arrays. Although it remains to be determined whether TNF-related weak inducer of apoptosis or TNF-related apoptosisinducing ligand, which are the ligands for DR3 and DR4/5, respectively, are expressed in infected dNP20 cultures, it is conceivable that prion replication induced apoptosis through the intrinsic pathway but not the DR-associated extrinsic pathway, because caspase-8 is cleaved by caspase-6 through its activation occurring downstream of caspase-3 and caspase-9 activation (61). More research will be required to determine the precise apoptotic signaling pathways induced by prion replication.
In summary, we developed a neurosphere-based cell culture model in which prion replication led to the development of a cytopathic effect and apoptotic cell death. Our current model offers a promising new approach for the study of prion-induced cytotoxicity. Since the hallmarks of prion pathology are neuronal loss and astrocytosis, one can argue that the present model showing cytopathic changes in astrocyte lineage cells does not recapitulate the disease process or prion toxicity. However, considering that neuronal apoptosis is currently considered the principal mechanism for neuronal loss in prion diseases, it is conceivable that prion replication may trigger possible common pathways in the cells of the present cultures and neurons, leading to late-occurring apoptosis. Thus, future research aimed at exploring how prion replication initiating apoptotic pathways in the current model could possibly provide clues to the molecular mechanisms of prion pathogenesis. In addition, this model could be a valuable tool for evaluating antiprion agents based on their ability to alleviate prion-induced cytotoxicity.
